Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Acquisitions (2021)

Beam Therapeutics (BEAM) has disclosed Acquisitions for 1 consecutive years, with $620000.0 as the latest value for Q1 2021.

  • Quarterly Acquisitions changed N/A to $620000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $620000.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $78000.0 for FY2025, N/A changed from the prior year.
  • Acquisitions for Q1 2021 was $620000.0 at Beam Therapeutics.
  • The five-year high for Acquisitions was $620000.0 in Q1 2021, with the low at $620000.0 in Q1 2021.